23andMe

close-up of a microbiological pipette in the genetic laboratory

Regulatory

23andMe bankruptcy sparks genetic data privacy concerns

Uncertainty over a new owner's policies and security risks through the court bidding process have customers and privacy advocates on edge.

Dave Muoio Mar 25, 2025 4:54pm

Two injectable medications with a tape measure wrapped around them

23andMe jumps into GLP-1 weight loss wave

Aug 12, 2024 4:00pm

downtown Austin Texas

SXSW 2023 healthcare recap: AI, genomics and health equity

Mar 17, 2023 2:00pm

23andM3 executive ring the Nasdaq opening bell on the day the company goes public

23andMe betting big on genomic service, therapeutics business

Oct 25, 2022 8:02am

close up of paper documents with business charts and tablet on a table

Digital health startups pulled in record-breaking $57.2B in 2021

Jan 21, 2022 10:49am

23andM3 executive ring the Nasdaq opening bell on the day the company goes public

Why data is 23andMe's 'secret power' for drug development

Jan 20, 2022 5:00pm